Operating Margin in % of GUIDED THERAPEUTICS INC from 2010 to Q3 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
GUIDED THERAPEUTICS INC quarterly/annual Operating Margin history and change rate from 2010 to Q3 2025.
  • GUIDED THERAPEUTICS INC Operating Margin for the quarter ending 30 Sep 2025 was -1.23K %, a 77.3% increase year-over-year.
  • GUIDED THERAPEUTICS INC annual Operating Margin for 2024 was -30.1K %, a 754% decline from 2023.
  • GUIDED THERAPEUTICS INC annual Operating Margin for 2023 was -3.53K %, a 86.2% increase from 2022.
  • GUIDED THERAPEUTICS INC annual Operating Margin for 2022 was -25.6K %, a 779% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

GUIDED THERAPEUTICS INC Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -1.23K +4.19K +77.3% 01 Jul 2025 30 Sep 2025
Q2 2025 -1.92K +3.66K +65.6% 01 Apr 2025 30 Jun 2025
Q1 2025 -216K -213K -5866% 01 Jan 2025 31 Mar 2025
Q4 2024 -30.1K -26.6K -754% 01 Oct 2024 31 Dec 2024
Q3 2024 -5.42K +516 +8.68% 01 Jul 2024 30 Sep 2024
Q2 2024 -5.59K +965 +14.7% 01 Apr 2024 30 Jun 2024
Q1 2024 -3.63K +8.82K +70.9% 01 Jan 2024 31 Mar 2024
Q4 2023 -3.53K +22.1K +86.2% 01 Oct 2023 31 Dec 2023
Q3 2023 -5.94K -2K -50.8% 01 Jul 2023 30 Sep 2023
Q2 2023 -6.55K -4.15K -173% 01 Apr 2023 30 Jun 2023
Q1 2023 -12.4K -10.1K -440% 01 Jan 2023 31 Mar 2023
Q4 2022 -25.6K -22.7K -779% 01 Oct 2022 31 Dec 2022
Q3 2022 -3.94K +755 +16.1% 01 Jul 2022 30 Sep 2022
Q2 2022 -2.4K -647 -36.9% 01 Apr 2022 30 Jun 2022
Q1 2022 -2.3K -704 -44% 01 Jan 2022 31 Mar 2022
Q4 2021 -2.92K -1.88K -183% 01 Oct 2021 31 Dec 2021
Q3 2021 -4.69K -3.69K -370% 01 Jul 2021 30 Sep 2021
Q2 2021 -1.75K +3.92K +69.1% 01 Apr 2021 30 Jun 2021
Q1 2021 -1.6K +3.52K +68.7% 01 Jan 2021 31 Mar 2021
Q4 2020 -1.03K +1.57K +60.4% 01 Oct 2020 31 Dec 2020
Q3 2020 -999 +936 +48.4% 01 Jul 2020 30 Sep 2020
Q2 2020 -5.67K -3.69K -187% 01 Apr 2020 30 Jun 2020
Q1 2020 -5.12K -3.11K -154% 01 Jan 2020 31 Mar 2020
Q4 2019 -2.6K +113 +4.16% 01 Oct 2019 31 Dec 2019
Q3 2019 -1.93K 01 Jul 2019 30 Sep 2019
Q2 2019 -1.98K 01 Apr 2019 30 Jun 2019
Q1 2019 -2.01K 01 Jan 2019 31 Mar 2019
Q4 2018 -2.72K 01 Oct 2018 31 Dec 2018
Q4 2015 -14.8K -1.49K -11.2% 01 Oct 2015 31 Dec 2015
Q3 2015 -15.4K -13.4K -676% 01 Jul 2015 30 Sep 2015
Q2 2015 -12.8K -11.2K -729% 01 Apr 2015 30 Jun 2015
Q1 2015 -13.2K -12.2K -1207% 01 Jan 2015 31 Mar 2015
Q4 2014 -13.3K -12.5K -1556% 01 Oct 2014 31 Dec 2014
Q3 2014 -1.98K -1.55K -359% 01 Jul 2014 30 Sep 2014
Q2 2014 -1.54K -1.26K -460% 01 Apr 2014 30 Jun 2014
Q1 2014 -1.01K -828 -447% 01 Jan 2014 31 Mar 2014
Q4 2013 -806 -677 -528% 01 Oct 2013 31 Dec 2013
Q3 2013 -432 -246 -132% 01 Jul 2013 30 Sep 2013
Q2 2013 -275 -58.5 -27.1% 01 Apr 2013 30 Jun 2013
Q1 2013 -185 +12.5 +6.32% 01 Jan 2013 31 Mar 2013
Q4 2012 -128 +59.6 +31.7% 01 Oct 2012 31 Dec 2012
Q3 2012 -186 01 Jul 2012 30 Sep 2012
Q2 2012 -216 01 Apr 2012 30 Jun 2012
Q1 2012 -198 01 Jan 2012 31 Mar 2012
Q4 2011 -188 01 Oct 2011 31 Dec 2011

GUIDED THERAPEUTICS INC Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -30.1K -26.6K -754% 01 Jan 2024 31 Dec 2024
2023 -3.53K +22.1K +86.2% 01 Jan 2023 31 Dec 2023
2022 -25.6K -22.7K -779% 01 Jan 2022 31 Dec 2022
2021 -2.92K -1.88K -183% 01 Jan 2021 31 Dec 2021
2020 -1.03K +1.57K +60.4% 01 Jan 2020 31 Dec 2020
2019 -2.6K +113 +4.16% 01 Jan 2019 31 Dec 2019
2018 -2.72K -1.44K -112% 01 Jan 2018 31 Dec 2018
2017 -1.28K 01 Jan 2017 31 Dec 2017
2015 -14.8K -1.49K -11.2% 01 Jan 2015 31 Dec 2015
2014 -13.3K -12.5K -1556% 01 Jan 2014 31 Dec 2014
2013 -806 -677 -528% 01 Jan 2013 31 Dec 2013
2012 -128 +59.6 +31.7% 01 Jan 2012 31 Dec 2012
2011 -188 -140 -290% 01 Jan 2011 31 Dec 2011
2010 -48.2 01 Jan 2010 31 Dec 2010
* An asterisk sign (*) next to the value indicates that the value is likely invalid.